Literature DB >> 27314957

Is distal motor and/or sensory demyelination a distinctive feature of anti-MAG neuropathy?

Pierre Lozeron1,2, Vincent Ribrag3, David Adams4,5, Marion Brisset6, Marguerite Vignon7, Marine Baron7, Marion Malphettes7, Marie Theaudin4, Bertrand Arnulf7, Nathalie Kubis6,8.   

Abstract

To report the frequency of the different patterns of sensory and motor electrophysiological demyelination distribution in patients with anti-MAG neuropathy in comparison with patients with IgM neuropathy without MAG reactivity (IgM-NP). Thirty-five anti-MAG patients at early disease stage (20.1 months) were compared to 23 patients with IgM-NP; 21 CIDP patients and 13 patients with CMT1a neuropathy were used as gold standard neuropathies with multifocal and homogeneous demyelination, respectively. In all groups, standard motor and sensory electrophysiological parameters, terminal latency index and modified F ratio were investigated. Motor electrophysiological demyelination was divided in four profiles: distal, homogeneous, proximal, and proximo-distal. Distal sensory and sensorimotor demyelination were evaluated. Anti-MAG neuropathy is a demyelinating neuropathy in 91 % of cases. In the upper limbs, reduced TLI is more frequent in anti-MAG neuropathy, compared to IgM-NP. But, predominant distal demyelination of the median nerve is encountered in only 43 % of anti-MAG neuropathy and is also common in IgM-NP (35 %). Homogeneous demyelination was the second most frequent pattern (31 %). Concordance of electrophysiological profiles across motor nerves trunks is low and median nerve is the main site of distal motor conduction slowing. Reduced sensory conduction velocities occurs in 14 % of patients without evidence of predominant distal slowing. Simultaneous sensory and motor distal slowing was more common in the median nerve of anti-MAG neuropathy than IgM-NP. Electrophysiological distal motor demyelination and sensory demyelination are not a distinctive feature of anti-MAG reactivity. In anti-MAG neuropathy it is mainly found in the median nerve suggesting a frequent nerve compression at wrist.

Entities:  

Keywords:  Anti-MAG; Distal; EMG; Nerve conduction; Neuropathy; TLI

Mesh:

Substances:

Year:  2016        PMID: 27314957     DOI: 10.1007/s00415-016-8187-z

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Length dependence in polyneuropathy associated with IgM gammopathy.

Authors:  Hessel Franssen; Nicolette C Notermans
Journal:  Ann Neurol       Date:  2006-02       Impact factor: 10.422

2.  European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of paraproteinemic demyelinating neuropathies. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society--first revision.

Authors: 
Journal:  J Peripher Nerv Syst       Date:  2010-09       Impact factor: 3.494

3.  Terminal latency index in neuropathy with antibodies against myelin-associated glycoproteins.

Authors:  Vitalie D Lupu; Carlos A Mora; Jim Dambrosia; Jacob Meer; Marinos Dalakas; Mary Kay Floeter
Journal:  Muscle Nerve       Date:  2007-02       Impact factor: 3.217

4.  Psychometric evaluation of a new sensory scale in immune-mediated polyneuropathies. Inflammatory Neuropathy Cause and Treatment (INCAT) Group.

Authors:  I S Merkies; P I Schmitz; F G van der Meché; P A van Doorn
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

5.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study.

Authors:  P J Dyck; K M Kratz; J L Karnes; W J Litchy; R Klein; J M Pach; D M Wilson; P C O'Brien; L J Melton; F J Service
Journal:  Neurology       Date:  1993-04       Impact factor: 9.910

6.  Nerve ultrasound findings in neuropathy associated with anti-myelin-associated glycoprotein antibodies.

Authors:  M Lucchetta; L Padua; G Granata; M Luigetti; M Campagnolo; C Dalla Torre; D Coraci; M Sabatelli; C Briani
Journal:  Eur J Neurol       Date:  2014-09-01       Impact factor: 6.089

7.  Polyneuropathy associated with monoclonal gammopathy of undetermined significance. A prospective study of the prognostic value of clinical and laboratory abnormalities.

Authors:  N C Notermans; J H Wokke; H M Lokhorst; H Franssen; Y van der Graaf; F G Jennekens
Journal:  Brain       Date:  1994-12       Impact factor: 13.501

Review 8.  Peripheral neuropathy and anti-MAG antibodies.

Authors:  N Latov; A P Hays; W H Sherman
Journal:  Crit Rev Neurobiol       Date:  1988

9.  Trial of baclofen in amyotrophic lateral sclerosis.

Authors:  F H Norris; K S U; B Sachais; M Carey
Journal:  Arch Neurol       Date:  1979-11

10.  Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy.

Authors:  M L Kuijf; M Eurelings; A P Tio-Gillen; P A van Doorn; L H van den Berg; H Hooijkaas; J Stork; N C Notermans; B C Jacobs
Journal:  Neurology       Date:  2009-09-01       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.